Patent Assignment
Reel/Frame 013718/0861
Assignment of Assignor's Interest
Recorded: 2003-06-10
Pages: 6
Assignor
BASF AKTIENGESELLSCHAFT
Executed: 2003-05-22
Assignee
ABBOTT GMBH & CO., KG
MAX-PLANCK-RING 2, WIESBADEN, 65205, GERMANY
Covered Properties
(61)
Tight Control of Gene Expression in Eucaryotic Cells by Tetracycline-Responsive Promoters
Patent:
5,650,298 →
Application:
08/260,452 →
Tetracycline-Inducible Transcriptional Activator and Tetracycline-Regulated Transcription Units
Patent:
5,654,168 →
Application:
08/275,876 →
Tetracycline-Regulated Transcriptional Inhibitors
Patent:
5,789,156 →
Application:
08/383,754 →
Novel Cysteine Protease Related to Interleukin-1 Beta Converting Enzyme
Application:
08/463,080 →
Antitumor Peptides
Patent:
5,831,002 →
Application:
08/472,453 →
Methods for Regulating Gene Expression
Patent:
5,888,981 →
Application:
08/479,306 →
Mice Transgenic for a Tetracycline-Controlled Transcriptional Activator
Patent:
5,859,310 →
Application:
08/481,970 →
Methods for Regulating Gene Expression
Patent:
6,004,941 →
Application:
08/485,740 →
Tetracycline Regulated Transcriptional Modulators with Altered Dna Binding Specificities
Patent:
5,589,362 →
Application:
08/485,971 →
Methods for Regulating Gene Expression
Patent:
5,814,618 →
Application:
08/485,978 →
Animals Transgenic for a Tetracycline-Regulated Transcriptional Inhibitor
Patent:
5,866,755 →
Application:
08/486,814 →
Mice Transgenic for a Tetracycline-Inducible Transcriptional Activator
Patent:
5,912,411 →
Application:
08/487,472 →
Modified Interleukin-1BETA Converting Enzyme with Increased Stability
Patent:
5,869,315 →
Application:
08/573,890 →
Substrates and Inhibitors for Cysteine Protease Ich-1
Patent:
6,288,037 →
Application:
08/665,643 →
Novel Active Peptide and Its Preparation
Patent:
5,864,012 →
Application:
08/732,453 →
Compounds Useful for the Synthesis of Dolastatin Analogs
Patent:
5,886,147 →
Application:
08/737,279 →
Novel Carboxylic Acid Derivatives, Their Preparation and Use in Treating Cancer
Patent:
6,030,975 →
Application:
08/818,622 →
Dolastatin-15 Derivatives in Combination with Taxanes
Patent:
6,103,698 →
Application:
08/819,101 →
Transcriptional Activators with Graded Transactivation Potential
Patent:
6,087,166 →
Application:
08/888,080 →
Dolastatin 15 Derivatives
Patent:
6,143,721 →
Application:
08/896,394 →
Methods for Producing Tetracycline-Regulated Transgenic Mice
Patent:
5,922,927 →
Application:
08/897,719 →
Hydroxamate Inhibitors of Interleukin-1B Converting Enzyme
Patent:
5,919,790 →
Application:
08/942,605 →
Transgenic Nonhuman Animal Having Functionally Disrupted Interleukin-1BETA Converting Enzyme Gene
Patent:
6,100,445 →
Application:
08/954,536 →
The Preparation of Active Peptides
Patent:
5,965,700 →
Application:
08/983,460 →
Substituted 4-Amino-7H-Pyrrolo(2,3,-D)-Pyrimidines as Ptk Inhibitors
Patent:
6,001,839 →
Application:
09/042,702 →
Transgenic Plants Having Tetracycline-Regulated Transcriptional Regulatory Systems
Patent:
6,242,667 →
Application:
09/161,902 →
Tetracycline-Inducible Transcriptional Activator Fusion Proteins
Patent:
6,136,954 →
Application:
09/162,184 →
Transgenic Organisms Having Tetracycline-Regulated Transcriptional Regulatory Systems
Patent:
6,252,136 →
Application:
09/163,269 →
Use of Aryl-Substituted Cyclobutylalkylamines for Treating Urinary Incontinence
Patent:
6,046,242 →
Application:
09/201,309 →
Compounds Useful for the Synthesis of Dolastatin Analogs
Patent:
6,248,865 →
Application:
09/211,013 →
Animals Transgenic for a Tetracycline-Regulated Transcriptional Inhibitor
Application:
09/241,347 →
Publication:
US 2004/0003417
Modified Interleukin-1B Converting Enzyme with Increased Stability
Patent:
6,242,240 →
Application:
09/248,179 →
Methods for Regulating Gene Expression
Sulfonamide Interleukin-1BETA Converting Enzyme Inhibitors
Patent:
6,316,415 →
Application:
09/284,422 →
Aspartate Ester Inhibitors of Interleukin-1BETA Converting Enzyme
Application:
09/284,424 →
Sulfonamide Substituted Aspartic Acid Interleukin-1BETA Converting Enzyme Inhibitors
Patent:
6,083,981 →
Application:
09/284,425 →
Methods and Compositions for Modulating Responsiveness to Corticosteroids
Application:
09/398,555 →
4-Aminopyrrolopyrimidines as Kinase Inhibitors
Tetracycline- Inducible Transcriptional Inhibitor Fusion Proteins
Patent:
6,271,348 →
Application:
09/489,777 →
Dolastatin-15 Derivatives in Combination with Taxanes
Patent:
6,632,795 →
Application:
09/520,254 →
Human Antibodies That Bind Human Il-12 and Methods for Producing
Patent:
6,914,128 →
Application:
09/534,717 →
Pyrrolopyrimidines as Therapeutic Agents
Indeno[1,2-C]-, Naphtho[1,2-C]- and Benzo[6,7] Cyclohepta [1,2-C]Pyrazole Derivatives
Patent:
6,451,834 →
Application:
09/541,222 →
Indeno[1,2-C]Pyrazole Derivatives for Inhibiting Tyrosine Kinase Activity
Patent:
6,534,655 →
Application:
09/541,309 →
Tricyclic Pyrazole Derivatives
Patent:
6,462,036 →
Application:
09/573,366 →
Transcriptional activators with graded transactivation potential
Patent:
6,271,341 →
Application:
09/577,027 →
Benzothiazinone and Benzoxazinone Compounds
Patent:
7,049,312 →
Application:
09/585,925 →
Dolastatin 15 Derivatives
Patent:
6,458,765 →
Application:
09/618,694 →
Kinase Inhibitors as Therapeutic Agents
Patent:
7,071,199 →
Application:
09/663,320 →
Pyrazolopyrimidines as Therapeutic Agents
Patent:
6,660,744 →
Application:
09/663,780 →
Therapeutic agents
Patent:
6,297,238 →
Application:
09/689,943 →
Antineoplastic Peptides
Application:
09/757,142 →
Publication:
US 2001/0009901
Tetracycline-Regulated Transcriptional Activator Fusion Proteins
Pyrazolopyrimidines as Therapeutic Agents
Modified Interleukin-1BETA Converting Enzyme with Increased Stability
Transgenic organisms having tetracycline-regulated transcriptional regulatory systems
Application:
09/874,389 →
Publication:
US 2002/0152489
Transgenic organisms having tetracycline-regulated transcriptional regulatory systems
Application:
09/892,227 →
Publication:
US 2002/0152487
Tetracycline-inducible transcriptional inhibitor fusion proteins
Application:
09/921,650 →
Publication:
US 2003/0022315
Transgenic organisms having transcriptional activators with graded transactivation potential
Application:
09/922,568 →
Publication:
US 2003/0049842
Sulfonamide interleukin-1beta converting enzyme inhibitors
Application:
09/964,114 →
Publication:
US 2002/0156094
Dolastatin 15 Derivatives
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 7, 2000
From: DOYLE, KEVIN; RAFFERTY, PAUL; STEELE, ROBERT; TURNER, ALLYSON
To: BASF AKTIENGESELLSCHAFT
Reel/Frame 011349/0531 →
Assignment of Assignor's Interest
Feb 21, 2003
From: BASF AKTIENGESELLSCHAFT
To: ABBOTT GMBH & CO. KG
Reel/Frame 013746/0941 →
Assignment of Assignor's Interest
May 6, 2004
From: BARON, UDO
To: TET SYSTEMS HOLDING GMBH & CO. KG
Reel/Frame 014601/0695 →
Assignment of Assignor's Interest
Nov 12, 2004
From: ABBOTT GMBH & CO. KG
To: TET SYSTEMS HOLDING GMBH & CO. KG
Reel/Frame 015370/0860 →
Assignment of Assignor's Interest
Jan 12, 2010
From: JANSSEN, BERND; BARLOZZARI, TERESA; HAUPT, ANDREAS; ZIERKE, THOMAS
To: BASF AKTIENGESELLSCHAFT
Reel/Frame 023765/0410 →
Assignment of Assignor's Interest
Jun 30, 2013
From: ABBOTT GMBH & CO KG
To: ABBVIE DEUTSCHLAND GMBH & CO KG
Reel/Frame 030716/0601 →
Assignment of Assignor's Interest
Jul 16, 2013
From: ABBOTT GMBH & CO KG
To: ABBVIE DEUTSCHLAND GMBH & CO KG
Reel/Frame 030805/0023 →